Lumontad, Christian Jade O.
HRN: 18-43-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2022
CEFTRIAXONE 1G (VIAL)
09/29/2022
10/05/2022
IV
2g
Q 24H
S/P Open Reduction External Fixation, L Femur
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes